Pentwater Capital’s overall interest up from 27.6 per cent so far this year to 28.6 per cent
Irish biopharmaceutical company stake part of package sold to Rosetta Capital
Market Beat: Life sciences company is finally delivering, six years after IPO
Irish life-sciences company invested $80m in Oxford-based company in July 2015
Markets report: Aryzta, BoI and PTSB fall but Malin bucks the trend on ISEQ to add 4.8%
Pentwater bought shares at 60% discount to Malin’s ‘intrinsic value’
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices